Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sten Stovall

London, UK
Sten Stovall is a London-based editor and writer with 40 years of experience in the field of journalism, including more than 20 years with Reuters and eight years with The Wall Street Journal/Dow Jones Newswires. He also has wide radio and television reporting experience and a solid network of contacts in the biopharma world. Sten is part of our team of specialist reporters, generating insightful features and analysis about R&D, product development, regulatory issues and industry trends for publications such as "The Pink Sheet", Scrip and IN VIVO.
Advertisement
Set Alert for Articles By Sten Stovall

Latest From Sten Stovall

Roche To Improve Real-World Cancer Data Extraction With Flatiron Buy

Acquisition reflects that regulatory-grade real-world evidence will play increasing role in drug discovery, development, commercialization and reimbursement.

Commercial M & A

Back To The Future: Mining Previous Trials For Future Drug Development

Researchers and companies will increasingly mine historical clinical data using new technologies to overcome patient scarcity and make sense of huge amounts of disparate data, Medidata says in a new report.

Clinical Trials Digital Health

Roche To Build RWE Cancer Data Extraction Role With Flatiron Buy

Acquisition reflects that regulatory-grade real-world evidence will play increasing role in drug discovery, development, commercialization and reimbursement.

Business Strategies Commercial

Hansa Medical's 'Game Changer' In Transplantations May Have Other Uses Too

Hansa Medical AB, a Swedish-listed, clinical-stage biotech, is focused on developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases that could change the face of kidney transplants.

Clinical Trials Commercial

Bavarian Nordic CEO Says Likely To Sell Imvamune Priority Review Voucher

Danish group believes its smallpox vaccine will get approved, generate a transferable priority review voucher, and replace the current US-licensed replicating smallpox vaccine ACAM2000.

Business Strategies Clinical Trials

Lundbeck's Rexulti Growth Hopes Clouded By Dementia Agitation Data Setback

Denmark-based Lundbeck's plans to make Rexulti the first approved drug for agitation associated with dementia have been knocked back by mixed clinical data, necessitating another Phase III trial.

Neurology Clinical Trials
See All
Advertisement
UsernamePublicRestriction

Register